Tecvayli 30mg Injection

Tecvayli 30mg Injection contains teclistamab, an anticancer medication classified as a bispecific monoclonal antibody. It is used to treat adult patients with relapsed or refractory multiple myeloma, a type of cancer affecting plasma cells in the bone marrow, who have received at least four prior lines of therapy, including a proteasome inhibitor, an immunomodulatory agent, and an anti-CD38 antibody. Tecvayli works by targeting and binding to both B-cell maturation antigen (BCMA) on myeloma cells and CD3 on T cells. This dual binding activates T cells to recognise and destroy BCMA-expressing myeloma cells. Inform your doctor before starting treatment, as Tecvayli 30mg Injection may lead to serious adverse effects including cytokine release syndrome (CRS), neurotoxicities, and infections. Regular monitoring and prompt management of these conditions are essential during therapy. Ensure you inform your physician of all medicines you are taking before commencing treatment with Tecvayli 30mg Injection. Report any symptoms such as difficulty breathing, cough, fever, chest pain, weakness, or seizures to your doctor.

To treat adult patients with relapsed or refractory multiple myeloma (a type of cancer affecting plasma cells in the bone marrow) who have previously received at least four lines of therapy, including a proteasome inhibitor, an immunomodulatory agent, and an anti-CD38 antibody.

Tecvayli 30mg Injection works by targeting and binding specifically to both B-cell maturation antigen (BCMA) on myeloma cells and CD3 on T cells. This dual binding activates T cells to recognise and destroy the BCMA-expressing myeloma cells, thereby inhibiting their growth and proliferation.

A healthcare professional administers Tecvayli 30mg Injection via intravenous infusion. The infusion is given over a specified duration as per your doctor’s treatment schedule. Do not self-administer the injection or alter the infusion schedule without consulting your healthcare provider.

Like all medications, Tecvayli 30mg Injection can cause side effects, although not everyone who takes it will experience them. Common: Cytokine release syndrome (fever, chills, nausea, fatigue) Neurological symptoms (headache, dizziness) Fatigue Injection site reactions Rare: Severe neurological symptoms (confusion, seizures) Difficulty breathing or swallowing Swelling of the face, lips, or tongue High fever Skin rash or severe skin reactions Rapid heartbeat

If you are undergoing any laboratory tests, inform your doctor that you are receiving a Tecvayli 30mg Injection. This medication may affect your laboratory results or the interpretation of certain tests. Tecvayli may also cause neurological symptoms. Your doctor may recommend monitoring for signs such as confusion or dizziness. Please report any new symptoms or changes in your condition to your doctor without delay.